Given PTEN's role in negatively regulating the PI3K/AKT pathway, this mutation could have profound effects on cellular growth and apoptosis regulation, further implicating PTEN loss as a driver in endometrial cancer. This evidence concerns the gene PTEN and endometrial cancer.